Label-Free Electrochemical Biosensors for Early Detection of Breast Cancer: A Systematic Review and Meta-Analysis of miRNA (miR-21, miR-155) and Exosome-Based Platforms

Manasa T L; Rajesh Kumar Upadhyay; Divyashree H B

Label-Free Electrochemical Biosensors for Early Detection of Breast Cancer: A Systematic Review and Meta-Analysis of miRNA (miR-21, miR-155) and Exosome-Based Platforms

Author(s)	Ms. Manasa T L, Dr. Rajesh Kumar Upadhyay, Dr. Divyashree H B
Country	India
Abstract	Breast cancer is the most prevalent cancer among women in the world and early diagnosis of cancer is the most important predictor of long-term survival. While currently popular screening tests such as mammograms and confirmatory tissue biopsies have drawbacks such as invasiveness, expense and less sensitivity in dense breast tissue, there has been a growing interest in minimally invasive molecular liquid-biopsy biomarkers. Among the analytes, miRNAs (in particular miR-21 and miR-155) and tumour derived exosomes are promising analytes because of their tight mechanistic relation to the oncosignalling pathways and/or their stability in biofluids. Alternatively, using a label free electrochemical biosensor in which the change of electron transfer at the interfaces is detected by the addition of the target molecule, can also be rapid, cost efficient and very sensitive for a fluorescence or enzyme linked assay. Systematic review and meta-analysis of the label-free electrochemical biosensing platforms used to detect miR-21, miR-155 and exosomes in the context of breast cancer diagnosis and prognosis are presented for the period 2021-2026. According to PRISMA guidelines, twenty primary studies were found from PubMed, ScienceDirect, Scopus, and Web of Science and were assessed for their sensor architecture and nanomaterial transducer, recognition element, limit of detection, linear dynamic range and clinical validation. The pooled estimates from the eleven diagnostic accuracy studies are 90% (0.88–93%) for the sensitivity and 92% (87–95%) for the specificity, and the summary area-under-curve is 0.94 (0.86–0.98). These application areas, such as electrode nanoarchitecture, aptamer/PNA probe design and CRISPR-assisted signal amplification, become the key areas of diagnostic performance, whereas reproducibility, interference with the biological matrix, and limited clinical-cohort validation appear to be the major barriers to bring laboratory prototypes to the point-of-car.
Keywords	Label-free biosensor, Electrochemical detection, Breast cancer, microRNA-21, microRNA-155, Exosome, Liquid biopsy, Systematic review, Meta-analysis
Field	Engineering
Published In	Volume 8, Issue 4, July-August 2026
Published On	2026-07-09

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI prefix of IJFMR is 10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 4 Cover Page Vol 8 Isu 3 Cover Page Vol 8 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Label-Free Electrochemical Biosensors for Early Detection of Breast Cancer: A Systematic Review and Meta-Analysis of miRNA (miR-21, miR-155) and Exosome-Based Platforms

Share this